Leukemia Clinical Trials in Cleveland

Showing 381-400 of 1,720 trials

STimulation to Activate RespIration

NCT06832306

Multi-center, randomized, controlled, open-label Phase 2 feasibility trial. Subjects on mechanical ventilation (MV) for acute hypoxemic respiratory failure (AHRF) with lung injury (including subjects who meet criteria for acute respiratory distress syndrome (ARDS)) will be randomized 2:1 to diaphragm neurostimulation-assisted ventilation (DNAV) using the AeroNova System plus lung-protective ventilation (Treatment) vs. lung-protective ventilation alone (Control).

ARDS (Moderate or Severe)AHRFMechanically Ventilated ICU Patients

Lungpacer Medical Inc.30 participantsStarted May 2025

La Jolla, California, United States • Shreveport, Louisiana, United States • Cleveland, Ohio, United States +3 more locations

COMPLETEDNA< 1 mile

3D Modalities for Medical Student Education of Congenital Heart Disease

NCT07295730

The goal of this clinical trial is to learn if 3D-printed heart models and augmented reality can be useful modalities to teach medical students about congenital heart disease. The main questions it aims to answer are: 1. Does using 3D-printed heart models improve learners' understanding of congenital heart disease when compared to traditional slide-based teaching methods? 2. Does using augmented reality heart models improve learners' understanding of congenital heart disease when compared to traditional slide-based teaching methods? 3. How can these modalities best be integrated into standard medical school curricula? Participants will: 1. Take a pre-test consisting of questions regarding anatomy and physiology of the normal heart as well as two congenital heart diseases. 2. Be randomized into 3 groups that receive a teaching session using either slide-based lecture, 3D-printed models, or augmented reality. 3. Take a post-test of the same questions from the pre-test. 4. Take a delayed post-test of the same questions with additional subjective questions about their experience with their assigned modality.

Tetralogy of Fallot (TOF)Hypoplastic Left Heart Syndrome (HLHS)

Case Western Reserve University26 participantsStarted Nov 2025

Cleveland, Ohio, United States

STimulation to Activate RespIration

3D Modalities for Medical Student Education of Congenital Heart Disease

Leukemia Trials in Other Cities

First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study

A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer

A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery

Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)

Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

Copanlisib and Nivolumab in Treating Patients With Richter's Transformation or Transformed Indolent Non-Hodgkin Lymphoma

DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer

Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.

Other Conditions in Cleveland